Neurocognitive impairment is correlated with oxidative stress in patients with moderate-to-severe obstructive sleep apnea hypopnea syndrome

Respiratory Medicine

Volumn 120, Issue , 2016, Pages 25-30

  He, Yanyu ^a   Chen, Rui ^a   Wang, Jing ^a   Pan, Wenying ^a   Sun, Yanqiu ^a   Han, Fei ^a   Wang, Qiaojun ^a   Liu, Chunfeng ^a,b  

^a THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

Author keywords

Cognitive impairment; Ischemia modified albumin; Obstructive sleep apnea hypopnea syndrome; Oxidative stress; Polysomnography

Indexed keywords

ADVANCED OXIDATION PROTEIN PRODUCT; BIOLOGICAL MARKER; ISCHEMIA MODIFIED ALBUMIN; MALONALDEHYDE; HUMAN SERUM ALBUMIN; ISCHEMIA-MODIFIED ALBUMIN; OXYGEN;

ADULT; ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; MONTREAL COGNITIVE ASSESSMENT; OXIDATIVE STRESS; PRIORITY JOURNAL; REM SLEEP; SCORING SYSTEM; SLEEP DISORDERED BREATHING; WAIST TO HEIGHT RATIO; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; COMPLICATION; DISORDERS OF HIGHER CEREBRAL FUNCTION; METABOLISM; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; PHYSIOLOGY; POLYSOMNOGRAPHY; PROCEDURES; SEVERITY OF ILLNESS INDEX; STANDARDS;

ADULT; ADVANCED OXIDATION PROTEIN PRODUCTS; ASIAN CONTINENTAL ANCESTRY GROUP; BIOMARKERS; FEMALE; HUMANS; MALE; MALONDIALDEHYDE; MIDDLE AGED; NEUROCOGNITIVE DISORDERS; NEUROPSYCHOLOGICAL TESTS; OXIDATIVE STRESS; OXYGEN; POLYSOMNOGRAPHY; SERUM ALBUMIN, HUMAN; SEVERITY OF ILLNESS INDEX; SLEEP APNEA, OBSTRUCTIVE; SLEEP, REM;

EID: 84988923783     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2016.09.009     Document Type: Article

References (27)

1. [1] Dempsey, J.A., Veasey, S.C., Morgan, B.J., et al. Pathophysiology of sleep apnea. Physiol. Rev. 90 (2010), 47–112.
2. [2] Chen, R., Xiong, K.P., Huang, J.Y., et al. Neurocognitive impairment in Chinese patients with obstructive sleep apnea hypopnea Syndrome. Respirology 16 (2011), 842–848.
3. [3] Bucks, R.S., Olaithe, M., Eastwood, P., Neurocognitive function in obstructive sleep apnoea: a meta review. Respirology 18 (2013), 61–70.
4. [4] Vaessen, T.J.A., Overeem, S., Sitskoorn, M.M., Cognitive complaints in obstructive sleep apnea. Sleep. Med. Rev. 19 (2015), 51–58.
5. [5] Kielb, S.A., Ancoli-Israel, S., Rebok, G.W., et al. Cognition in obstructive sleep apnea-hypopnea syndrome (OSAS): current clinical knowledge and the impact of treatment. Neuromol. Med. 14 (2012), 180–193.
6. [6] Rosenzweig, I., Williams, S.C., Morrell, M.J., The impact of sleep and hypoxia on the brain: potential mechanisms for the effects of obstructive sleep apnea. Curr. Opin. Pulm. Med. 20 (2014), 565–571.
7. [7] Rosenzweig, I., Glasser, M., Polsek, D., et al. Sleep apnoea and the brain: a complex relationship. Lancet Respir. Med. 3 (2015), 404–414.
8. [8] Daulatzai, M.A., Evidence of neurodegeneration in obstructive sleep apnea: relationship between obstructive sleep apnea and cognitive dysfunction in the elderly. J. Neurosci. Res. 93 (2015), 1778–1794.
9. [9] Wang, Y., Zhang, S.X.L., Gozal, D., Reactive oxygen species and the brain in sleep apnea. Respir. Physiol. Neurobiol. 174 (2010), 307–316.
10. [10] Kizawa, T., Nakamura, Y., Takahashi, S., et al. Pathogenic role of angiotensin II and oxidised LDL in obstructive sleep apnoea. Eur. Respir. J. 34 (2009), 1390–1398.
11. [11] Mancuso, M., Bonanni, E., LoGerfo, A., et al. Oxidative stress biomarkers in patients with untreated obstructive sleep apnea syndrome. Sleep. Med. 13 (2012), 632–636.
12. [12] Sales, L.V., Bruin, V.M., D'Almeida, V., et al. Cognition and biomarkers of oxidative stress in obstructive sleep apnea. Clin. (Sao Paulo) 68 (2013), 449–455.
13. [13] Kaefer, M., Piva, S.J., De Carvalho, J.A., et al. Association between ischemia modified albumin, inflammation and hyperglycemia in type 2 diabetes mellitus. Clin. Biochem. 43 (2010), 450–454.
14. [14] Zuwała-Jagiełło, J., Warwas, M., Pazgan-Simon, M., Ischemia-modified albumin (IMA) is increased in patients with chronic hepatitis C infection and related to markers of oxidative stress and inflammation. Acta Biochim. Pol. 59 (2012), 661–667.
15. [15] Altunoglu, E., Guntas, G., Erdenen, F., et al. Ischemia modified albumin and advanced oxidation protein products as potential biomarkers of protein oxidation in Alzheimer's disease. Geriatr. Gerontol. Int. 15 (2015), 872–880.
16. [16] Can, M., Varlibas, F., Guven, B., et al. Ischemia modified albumin and plasma oxidative stress markers in Alzheimer's disease. Eur. Neurol. 69 (2013), 377–380.
17. [17] Nasreddine, Z.S., Phillips, N.A., Bédirian, V., et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J. Am. Geriatr. Soc. 53 (2005), 695–699.
18. [18] American Academy of Sleep Medicine, The International Classification of Sleep Disorders: Diagnostic and Coding Manual. second ed., 2005, American Academy of Sleep Medicine, Westchester, IL.
19. [19] Berry, R.B., Budhiraja, R., Gottlieb, D.J., et al. Rules for scoring respiratory events in sleep: update of the 2007 AASM manual for the scoring of sleep and associated events. J. Clin. Sleep. Med. 8 (2012), 597–619.
20. [20] Petersen, R.C., Doody, R., Kurz, A., et al. Current concepts in mild cognitive impairment. Arch. Neurol. 58 (2001), 1985–1992.
21. [21] Johns, M.W., A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14 (1991), 540–545.
22. [22] Folstein, M.F., Folstein, S.E., McHugh, P.R., “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12 (1975), 189–198.
23. [23] Olaithe, M., Bucks, R.S., Executive dysfunction in OSA before and after treatment: a meta-analysis. Sleep 36 (2013), 1297–1305.
24. [24] Crawford-Achour, E., Dauphinot, V., Martin, M.S., et al. Protective effect of long-term CPAP therapy on cognitive performance in elderly patients with severe OSA: the PROOF study. J. Clin. Sleep. Med. 11 (2015), 519–524.
25. [25] Yang, L.X., Ma, S.G., Liu, H., et al. Influence of obstructive sleep apnea on serum butyrylcholinesterase activity and ischemia-modified albumin levels. Clin. (Sao Paulo) 68 (2013), 968–973.
26. [26] Song, Y., Blackwell, T., Yaffe, K., et al. Relationships between sleep stages and changes in cognitive function in older men: the MrOS sleep study. Sleep 38 (2014), 411–421.
27. [27] Maestri, M., Carnicelli, L., Tognoni, G., et al. Non-rapid eye movement sleep instability in mild cognitive impairment: a pilot study. Sleep. Med. 16 (2015), 1139–1145.